Tuesday, September 20, 2016

Mylan shares languish at low valuation as EpiPen hearing nears

NEW YORK, Sept 20 (Reuters) - Shares of Mylan NV are

trading at historically low valuations as the company's chief

executive officer is set to face a congressional grilling on

Wednesday over the...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)